Pharmacological activation of the nuclear receptor REV-ERB reverses cognitive deficits and reduces amyloid-β burden in a mouse model of Alzheimer’s disease

Overview of attention for article published in PLOS ONE, April 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 22 Dimensions

Readers on

mendeley: 55 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 8 X posts from 3 X users, with an upper bound of 11,422 followers.

Pharmacological activation of the nuclear receptor REV-ERB reverses cognitive deficits and reduces amyloid-β burden… https://t.co/cVeNjGVOJi

29 Apr 2023

Reply Repost Favourite

RT @Meddocslu: #PLOSONE: Pharmacological activation of the nuclear receptor REV-ERB reverses cognitive deficits and reduces ... https://t.…

22 Oct 2020

Reply Repost Favourite

#PLOSONE: Pharmacological activation of the nuclear receptor REV-ERB reverses cognitive deficits and reduces ... https://t.co/avbvl2HLNy

22 Oct 2020

Reply Repost Favourite

Pharmacological activation of the nuclear receptor REV-ERB reverses cognitive deficits and reduces amyloid-β burden in a mouse model of Alzheimer's... - PubMed - NCBI https://t.co/hR5e64y1VF

23 Dec 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 4 additional X posts.